Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-7339
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer ; day:20 ; month:4 ; year:2017 ; pages:1-7
Supportive care in cancer ; (20.4.2017), 1-7
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Korkeila, E. A.
- Beteiligte Personen und Organisationen
-
Salminen, T.
Kallio, R.
Mikkola, M.
Auvinen, P.
Pyrhönen, S.
Ristamäki, R.
SpringerLink (Online service)
- DOI
-
10.1007/s00520-017-3689-5
- URN
-
urn:nbn:de:1111-201705046286
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
07.11.2025, 11:09 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Korkeila, E. A.
- Salminen, T.
- Kallio, R.
- Mikkola, M.
- Auvinen, P.
- Pyrhönen, S.
- Ristamäki, R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma
Initial experience in staging primary oesophageal/gastro-oesophageal cancer with 18F-FDG PET/MRI
Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma
Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma
Mucosal neuroimmune mechanisms in gastro-oesophageal reflux disease (GORD) pathogenesis
Development of an implant to treat gastro-oesophageal reflux disease
Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology – an update for the surgical oncologist
Impact of gastro-oesophageal reflux on microRNA expression, location and function
Neoadjuvant docetaxel and capecitabine (TX) versus docetaxel and epirubicin (TE) for locally advanced or early her2-negative breast cancer: an open-label, randomized, multi-center, phase II Trial
Endoscopic Removal of an Angelchik Prosthesis after Migration through the Gastro-Oesophageal Junction
The impact of operative approach on outcome of surgery for gastro-oesophageal tumours
The prevalence of dental erosion in Nigerian patients with gastro-oesophageal reflux disease
Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma
Initial experience in staging primary oesophageal/gastro-oesophageal cancer with 18F-FDG PET/MRI
Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma
Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma
Mucosal neuroimmune mechanisms in gastro-oesophageal reflux disease (GORD) pathogenesis
Development of an implant to treat gastro-oesophageal reflux disease
Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology – an update for the surgical oncologist
Impact of gastro-oesophageal reflux on microRNA expression, location and function
Neoadjuvant docetaxel and capecitabine (TX) versus docetaxel and epirubicin (TE) for locally advanced or early her2-negative breast cancer: an open-label, randomized, multi-center, phase II Trial
Endoscopic Removal of an Angelchik Prosthesis after Migration through the Gastro-Oesophageal Junction
The impact of operative approach on outcome of surgery for gastro-oesophageal tumours
The prevalence of dental erosion in Nigerian patients with gastro-oesophageal reflux disease
Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma
Initial experience in staging primary oesophageal/gastro-oesophageal cancer with 18F-FDG PET/MRI
Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma
Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma
Mucosal neuroimmune mechanisms in gastro-oesophageal reflux disease (GORD) pathogenesis
Development of an implant to treat gastro-oesophageal reflux disease
Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology – an update for the surgical oncologist
Impact of gastro-oesophageal reflux on microRNA expression, location and function
Neoadjuvant docetaxel and capecitabine (TX) versus docetaxel and epirubicin (TE) for locally advanced or early her2-negative breast cancer: an open-label, randomized, multi-center, phase II Trial
Endoscopic Removal of an Angelchik Prosthesis after Migration through the Gastro-Oesophageal Junction
The impact of operative approach on outcome of surgery for gastro-oesophageal tumours